MyLymphomaTeam

What is the recurrence rate after autologous stem cell transplant for DLBCL with a single focal lesion following RICE treatment?

The search results don't provide specific recurrence rates for DLBCL patients with a single focal lesion who received RICE treatment followed by autologous stem cell transplant. However, some Show Full Answer

What is the recurrence rate after autologous stem cell transplant for DLBCL with a single focal lesion following RICE treatment?

The search results don't provide specific recurrence rates for DLBCL patients with a single focal lesion who received RICE treatment followed by autologous stem cell transplant. However, some general information about relapse after treatment may be helpful.

For DLBCL patients who achieve complete response after initial R-CHOP treatment, about one-third will relapse within two years. When DLBCL relapses and patients receive second-line treatment (which often includes autologous bone marrow transplant), approximately 44 percent achieve a second remission.

The longer you stay in remission after transplant, the lower your chances of relapse become. Studies show that after achieving complete response for two years:
- 6.9 percent relapsed after three years
- 9.3 percent relapsed after five years
- 10.3 percent relapsed after eight years

Your specific situation with a single focal lesion and RICE treatment may affect your individual outlook. It's important to discuss your personal risk factors and prognosis with your oncology team, as they can consider all aspects of your case including your response to treatment and other prognostic factors.

 AI-generated responses are not a substitute for medical advice. These services are not intended to diagnose, treat, or cure any condition or disease. Always ask your doctor about specific health concerns.

DLBCL Relapse Rate and Treatment Options